Data as of Aug 22
| +0.54 / +1.24%|
The 13 analysts offering 12-month price forecasts for DexCom Inc have a median target of 46.00, with a high estimate of 53.00 and a low estimate of 28.50. The median estimate represents a +4.36% increase from the last price of 44.08.
The current consensus among 14 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.